BioNovix Management Team

Index | Xanthohumol Research | Testimonies | Opportunity | Info Request  

People of Albany California SEE

BioNovix was formed to bring two exciting new health products to market:

• MeridiumXN™ – a patented bioactive biopharmaceutical compound that addresses core health and wellness issues.
• The Wellness Index Test™ – a revolutionary approach to measuring how much oxidative stress your body is experiencing while providing an objective, scientific, and reliable indication of your overall wellness.

PRESS RELEASE 12/8/06: Dr. Morrow, who is a member of the BioNovix Scientific Advisory Board, was recently honored for his research on free radicals.

---

Our management team brings unmatched experience and ability to our entry into the nutraceutical, consumer health products, and network marketing arenas:

Eric H. Kuhrts, Chairman of the Board and Chief Science Officer

Eric is the founder and CEO of five pharmaceutical companies, and is the inventor of over 30 issued and pending patent applications. He has been involved in numerous aspects of management and research related to pharmaceuticals, diagnostics, and consumer products for over 18 years. One of his inventions, the Bios® Life2 generated over $180 million dollars in annual revenues (close to $2 billion in sales over a 10 year period) for the Rexall Sundown company’s Rexall Showcase International network marketing division, and paid millions in royalties before being sold for a substantial projected royalty stream. Eric has developed and licensed novel proprietary diagnostic biomarkers, major sports supplement products, numerous over-the counter (OTC) drug products, drug delivery systems, and many new biopharmaceutical formulations in the cardiovascular, and anti-inflammatory area. Eric also has extensive experience in the development of new drugs that require FDA approval via new drug application (IND/NDA) submissions. Eric is a graduate of the University of California at San Diego.

Fred Auzenne, CEO and President

Fred is currently serving as CEO of Sedona Labs, Inc. Fred spent seven years in U.S. Army Intelligence followed by a successful 15-year career in sales and marketing within the casino, pharmaceutical (Merck) and medical device (Medtronic) industries. At Sedona Labs, Fred boosted sales nearly 90% in less than 6 months. He also initiated a successful reorganization and restructuring to improve IT systems, shipping, manufacturing, communications and purchasing. He guided the company through the launch of three new products that are positioned to achieve multi-million dollar sales growth through premier retailers such as Wild Oats, Whole Foods and Trader Joes. Fred holds an MBA from University of Nevada, Reno.

Roger C. Hill, Vice President, U.S. Sales

Roger brings demonstrated accomplishments in strategic sales and marketing productivity to BioNovix. He joins the company from Global Health Trax, a leading nutraceutical manufacturing and wholesale distributor of proprietary health and wellness products where he developed and expanded an independent distributor base of 10,000 in the U.S. and Japan. Previously, he was responsible for $52 million in network marketing revenue as Director of Sales at Acceris Communications. Roger has a bachelors degree in business administration and accounting from California State University San Marcos.

Dave Holker, Vice President, International Sales

Dave brings a wealth of Network Marketing experience to BioNovix. He has been involved within the Network Marketing
industry for over 30 years. In the field, he has built large and successful distributor organizations. On the corporate side, a partial
list of who he has consulted to and/or worked in administrative positions with includes: Forever Living Products, Nature Sunshine
Products, 21st Century Nutraceuticals, Sunrider, Healing America, Body Extreme, and Ztel Communications. Just prior to
joining the BioNovix team, he was Vice President of Sales/Marketing with Enliven International. While serving in that capacity,
monthly sales went from under $500,000 to over $2,500,000 in 14 months.  In November 2005, Dave served as the Honorary
Chairman of the First Forum for Globalization of Traditional Chinese Medicine held in Beijing and authorized by the Central
Organizing Committee of the Chinese Government.  Dave speak Mandarin Chinese and has a degree in Business Administration
from Brigham Young University.

Reshma Block, Executive Vice President, Director of Operations

Reshma comes to BioNovix with a proven background in both Information Technology management and entrepreneurialism. She has 10 years of successful IT leadership experience with the Intel Corporation where her responsibilities included managing various global engineering teams and large IT suppliers, implementing and managing server solutions and data center technologies in a global 24x7 environment. In addition, she drove key architecture and engineering decisions for Intel’s next generation computing infrastructure for it’s world-wide data centers. Reshma received her MBA from Pepperdine University.

Mark James Smith, CPA, Vice President, Finance

Mark contributes deep experience in corporate and public accounting to the BioNovix management team. He was Director of Finance for Planet Hollywood International for six years where he managed an accounting staff of 45 controllers spanning domestic and international locations. He developed and implemented the company’s primary systems of accounting and financial controls and later played a leadership role in the company’s initial public offering and subsequent bond issue. Previously, Mark was an Audit Manager at KPMG Peat Marwick where he planned and supervised audit engagements and report issuance for private and public corporations in the manufacturing, financial, real estate, and hospitality industries. Mark has a bachelors of science with emphasis in accounting from Arizona State University.

Lisa Peterson, Vice President, Marketing

Lisa brings extensive expertise in consumer products to BioNovix. She has been a leader in transforming businesses and brands in the personal care area as well as the health and wellness industry. Prior to joining the company, Lisa was founder and creative director of a design firm. For over 18 years she and her firm worked with Fortune 500 companies in developing overall positioning and brand architecture. She also directed research in patterning influences, formulated strategic principles and created equity building assets for her clients. Lisa received her BFA from Ohio University.

---

The company is in the early stages of building a Scientific Advisory Board to assist us in establishing the direction of future research and product development, while serving as spokespersons for the science that underlies our existing products. To date, we have successfully recruited two of the most distinguished and active scientists in the area of isoprostane research:

• L. Jackson Roberts II, M.D., Professor of Medicine and Pharmacology, Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine.  Dr. Roberts is an internationally renowned professor of Pharmacology and Medicine whose discovery of isoprostanes—compounds important in the measurement of free-radical damage—has given researchers the ability to reliably quantify oxidative stress. In the past 10 years, Roberts has given more than 50 invited presentations—including the keynote address at the First European Workshop on Isoprostanes—and authored more than 120 articles in referred journals. For his discovery of isoprostanes, the Society of Free Radical Biology and Medicine selected him for its Lifetime Achievement Award.
  Dr. Roberts was also presented with the Earl Sutherland Prize for Achievement in Research on August 24, 2006: http://www.vanderbilt.edu/register/articles?id=28233
  
• Jason D. Morrow, M.D., F. Tremaine Billings Professor of Medicine, Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine. Dr. Morrow is the Principal Investigator at the Jason D. Morrow Laboratory. The laboratory's research focuses primarily on the biochemistry and pharmacology of isoprostanes. The importance of this work is that the isoprostanes exert potent biological activity and represent the most accurate method to assess oxidative stress status in vivo in humans, revolutionizing the examination of oxidant injury in disease processes.
  
  Dr. Morrow honored for his research on free radicals: http://www.mc.vanderbilt.edu/reporter/index.html?ID=5204

Copyright © 2006-2008 - MANE World Promotions, Inc.

Index | Xanthohumol Research | Testimonies | Opportunity | Info Request